11:02 AM EST - GeneNews Limited : Today announced operational and financial results for the three-month period ended September 30, 2017. GeneNews reported a consolidated net loss of $0.6 million, or $0.01 loss per common share, as compared with a consolidated net loss of $2.8 million, or $0.04loss per common share, for the three-month period ended September 30, 2016. All figures in U.S. dollars. GeneNews Limited
shares T.GEN are trading down $0.02 at $0.12.
